SCHEMBL28026523

SCHEMBL28026523

CC1(C(=O)O)C=CC(c2ccc(F)cc2)=C(C(=O)O)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.39
BAD Q92934 1/20 0.39
HSD11B1 P28845 2/20 0.34
CCR2 P41597 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
APP P05067 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
APAF1 O14727 1/20 0.33
POLB P06746 1/20 0.33
GRK2 P25098 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
HCAR3 P49019 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CA12 O43570 1/20 0.31
ALPL P05186 1/20 0.31
RPA1 P27694 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28005777 0.86 DHODH (0.32) CCR2ALDH1A1RARARARBRARG
SCHEMBL28065629 0.85 FPR2 (0.33) KMT2A
SCHEMBL28853365 0.85 ALPL (0.31) POLBALPLKMT2A
SCHEMBL28014013 0.85 MAPK1 (0.35) CCR2PTGS1PTGS2POLBKMT2A
SCHEMBL28069748 0.82 CA1 (0.32)
SCHEMBL28841114 0.82 CES2 (0.33)
SCHEMBL28164688 0.80 CYP3A4 (0.31) CYP3A4
SCHEMBL28049312 0.79 RXRA (0.34)
SCHEMBL28138029 0.77 CA1 (0.37) POLBHCAR3HCAR2GPR35
SCHEMBL27332909 0.76 HPGDS (0.38) CYP3A4CYP2C9HCAR2CA12RARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104837844-B Pyrazole substituted imidazopiperazines as casein kinase 1D/E inhibitors 百时美施贵宝公司 2017-08-29 CN disclosed
CN-104837844-A Pyrazole substituted imidazopiperazines as casein kinase 1D/E inhibitors BRISTOL MYERS SQUIBB CO 2015-08-12 CN disclosed